Roger L Albin, MD

Roger Albin, MD
Anne B Young Legacy Professor of Neurology
Professor of Neurology and Section Head
Co-Division Chief Movement
Medical School
[email protected]
Available to mentor
Roger L Albin, MD
Roger Albin, MD
Professor
  • Center Memberships
  • Recent Publications
  • Manage Your Profile

  • Center Memberships

    • Center Member
      Frankel Institute for Heart and Brain Health

    Recent Publications

    See All Publications
    • Journal Article
      Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
      Lim KS, Periñan MT, Chew EGY, Lee PS, Akçimen F, Lim JL, Koretsky MJ, Funayama M, Yoshino H, Hattori N, Kaiyrzhanov R, Houlden H, Isayan M, Tay YW, Toh TS, Lit LC, Khairul Anuar AN, Ding HX, Screven L, Ibrahim NM, Lin CH, Kim HJ, Lee JY, Chung SJ, Foo JN, Tan EK, Lim SY, Tan AH, Bandres-Ciga S, Ahmad-Annuar A, Atadzhanov M, Nguyen T, Nguyen D, Foroud T, Xie T, Walker R, Alcalay R, Albin R, Shulman L, Dean M, Ruffrage L, Chahine LM, Marek K, Markopoulou K, Kieburtz K, Nuytemans K, Shulman J, Inca-Martinez M, Jankovic J, Lubbe S, Mencacci NE, Keller Sarmiento IJ, Chen H, Beach T, Serrano GE, Dumanis S, Riley E, Williamson J, Shamim E, Hall D, Wegel C, Pantazis CB, Cruchaga C, Jonas C, Sobering AK, Sherer T, Chowdhury S, Louie N, Kuhl M, Murphy K, Solle JC, Comart C, Fiske B, Casey B, Siddiqi B, O’Grady A, Marsili L, Espay A, Stott S, Love S, Lewis PA, Williams N, Mok KY, Grosset D, Bale C, Carroll C, Obese V, Jasaitye S, Weil R, Okunoye O, Wood N, Hardy J, Morris H, Stafford EJ, Schapira A, Schrag A, Martínez-Carrasco A, Genc G, Ertan S, Çakmak ÖÖ. Npj Parkinson S Disease, 2026 Dec 1; 12 (1): DOI:10.1038/s41531-026-01265-3
    • Journal Article
      Author Correction: TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations (npj Parkinson's Disease, (2025), 11, 1, (348), 10.1038/s41531-025-01180-z)
      Sun W, Schulte C, Gasser T, Tan M, Atadzhanov M, Nguyen T, Nguyen D, Foroud T, Xie T, Walker R, Alcalay R, Albin R, Shulman L, Dean M, Ruffrage L, Chahine LM, Marek K, Markopoulou K, Kieburtz K, Nuytemans K, Shulman J, Inca-Martinez M, Jankovic J, Lubbe S, Mencacci NE, Sarmiento IJK, Chen H, Beach T, Serrano GE, Dumanis S, Riley E, Williamson J, Shamim E, Hall D, Wegel C, Pantazis CB, Cruchaga C, Jonas C, Sobering AK, Sherer T, Chowdhury S, Louie N, Kuhl M, Murphy K, Solle JC, Comart C, Fiske B, Casey B, Siddiqi B, O’Grady A, Marsili L, Espay A, Stott S, Love S, Lewis PA, Williams N, Mok KY, Grosset D, Bale C, Carroll C, Obese V, Jasaitye S, Weil R, Kaiyrzhanov R, Okunoye O, Wood N, Hardy J, Morris HR, Houlden H, Stafford EJ, Schapira A, Schrag A, Martínez-Carrasco A, Genc G, Ertan S, Çakmak ÖÖ, Başak AN, Ben Sassi S, Amouri R, Wu S, Kung PJ, Wu YR, Wu HC, Wu RM, Lin CH, Krack P, Zweier C, El-Sadig S, Pastor P, Beyer K, Hoenicka J, Alvarez I, Cubo E, Kim YJ, Jeon B, Bardien S, Carr J, Amod F, Tan EK, Umair M. Npj Parkinson S Disease, 2026 Dec 1; 12 (1): DOI:10.1038/s41531-026-01351-6
    • Journal Article
      Genetic modifiers of APOE-ε4-associated cognitive decline
      Contreras AG, Walters S, Eissman JM, Archer DB, Regelson AN, Durant A, Clifton M, Mukherjee S, Lee ML, Choi SE, Scollard P, Trittschuh EH, Mez J, Bush WS, Kunkle BW, Cruchaga C, Naj AC, Gifford KA, Bilgel M, Kuzma AB, Raj BA, Fargher K, Smith A, Raudin L, Chaing G, Relkin N, Smith KE, Shim H, Ponto LLB, Schultz SK, Sarrael A, Hernando R, Pomara N, Drost D, Rachinsky I, Pasternak S, Finger E, Bachman D, Spicer K, Mintzer J, Miller BL, Rosen HJ, Correia S, Malloy P, Salloway S, Tremont G, Querfurth H, Ott BR, Watkins F, Garg P, Williamson JD, Sink KM, Schwartz ES, Kitzmiller TJ, Santulli RB, Anderson K, Blank K, Pearlson GD, Brown AD, Celmins D, Zimmerman EA, Adeli A, Kataki M, Scharre DW, Rainka M, Capote H, Bates V, Reeder S, Tariot P, Nguyen D, Preda A, Carlsson CM, Asthana S, Bartha R, Lee TY, Borrie M, Kittur S, Carmichael O, Fletcher E, Hudson L, Ogrocki P, Lerner A, Allard J, Wolday S, Obisesan TO, Johnson PL, Norbash A, Budson AE, Killiany R, Kowall N, Sirrel SA, Jacobson SA, Belden CM, Sabbagh MN, Tinklenberg J, Rosen A, Lane B, Taylor JL, Yesavage J, Frey M. Nature Communications, 2026 Dec 1; 17 (1): DOI:10.1038/s41467-026-68933-z
      PMID: 41720779
    • Journal Article
      The Dark Matter of Levodopa Pharmacodynamics
      Albin RL, Leventhal DK, Mahlknecht P. Movement Disorders, 2026 May 27; DOI:10.1002/mds.70372
    • Journal Article
      Cholinergic system changes in levodopa-unresponsive freezing of gait and failure of goal-directed motor behavior in Parkinson's disease.
      Bohnen NI, Roytman S, Carli G, Chou KL, Kanel P, Albin RL. Neural Regen Res, 2026 May 14; DOI:10.4103/NRR.NRR-D-25-01957
      PMID: 42199104
    • Journal Article
      White matter lesions disrupt cholinergic pathways important for cognition in Parkinson's disease.
      Carli G, Brown T, Michalakis F, Biddix A, Roytman S, Vangel R, Van Hout A, Kanel P, Scott P, Albin RL, Bohnen NI. Brain, 2026 May 12; DOI:10.1093/brain/awag172
      PMID: 42117428
    • Journal Article
      Genome-wide association study of copy number variations in Parkinson's disease.
      Landoulsi Z, Sreelatha AAK, Kuznetsov N, Schulte C, Bobbili DR, Montanucci L, Leu C, Niestroj L-M, Hassanin E, Domenighetti C, Sugier P-E, Radivojkov-Blagojevic M, Lichtner P, Portugal B, Edsall C, Krüger J, Hernandez DG, Blauwendraat C, Mellick GD, Zimprich A, Pirker W, Tan M, Rogaeva E, Lang A, Koks S, Taba P, Lesage S, Brice A, Corvol J-C, Chartier-Harlin M-C, Mutez E, Brockmann K, Deutschländer AB, Hadjigeorgiou GM, Dardiotis E, Stefanis L, Simitsi AM, Valente EM, Petrucci S, Straniero L, Zecchinelli A, Pezzoli G, Brighina L, Ferrarese C, Annesi G, Quattrone A, Gagliardi M, Burbulla LF, Matsuo H, Nakayama A, Hattori N, Nishioka K, Chung SJ, Kim YJ, Pavelka L, Kolber P, van de Warrenburg BP, Bloem BR, Singleton AB, Vitale D, Toft M, Pihlstrom L, Guedes LC, Ferreira JJ, Bardien S, Carr J, Tolosa E, Ezquerra M, Pastor P, Wirdefeldt K, Pedersen NL, Ran C, Belin AC, Puschmann A, Clarke CE, Morrison KE, Krainc D, Farrer MJ, Lal D, Global Parkinson Genetics Program (GP2) , Elbaz A, Gasser T, Krüger R, Sharma M, May P, Comprehensive Unbiased Risk Factor Assessment for Genetics and Environment in Parkinson’s Disease (COURAGE-PD) consortium . NPJ Parkinsons Dis, 2026 Apr 20; DOI:10.1038/s41531-025-01245-z
      PMID: 42009659
    • Preprint
      Cholinergic substrates of gait and postural impairments in Progressive Supranuclear Palsy.
      Kanel P, Carli G, Roytman S, van der Zee S, Vangel R, Barr J, Brown T, Spears CC, Narkis A, Slingerland S, Meles S, van Laar T, Scott PJH, Albin RL, Bohnen NI. 2026 Feb 4; DOI:10.21203/rs.3.rs-8778777/v1
      PMID: 41674844

    Featured News & Stories

    Department News

    Parkinson disease and normal aging

    Learn about Parkinson disease and normal aging, according to a University of Michigan expert.
    Department News

    Clinical trials that will shape medicine In 2023

    Clinical trials that will shape medicine In 2023